KFX Medical, LLC
USPTO PatentsView assignee record - 7 granted patents across 2 technology areas, recorded in grant years 2015–2020. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).
The verdict
According to USPTO PatentsView, KFX ranks #36,117 of 49,997 tracked US assignees by granted-patent volume, with 7 patents across 2 technology areas.
- #36,117
- of 49,997 US assignees by volume
- 10th percentile
- by Innovation Score (22.0/100)
- 16.4
- avg claims per patent
- -83%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R36117 · US Corporation #36,117 · 7 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-DROP · BOOK-FULL
- GRANTS-MICRO 7 grants
- MID-PACK #36,117/49,997
- PHOTO-FINISH Kenda Rubber IND
- CPC-NARROW A61B · 2 areas
- INNOV-THIN 22.0/100
- CLAIMS-RICH 16.4 claims/avg
- TYPE-USCORP US Corporation
- VEL-DROP -83% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Kenda Rubber IND. Co., Ltd. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How KFX’s 22.0 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around KFX
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- KFX Medical · this assignee 22
KFX Medical · this assignee
22 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows KFX's Innovation Score is 22.0/100 (10th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for KFX?
Each dot is one of KFX’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). KFX’s own 16.4 claims/patent is ABOVE the 6.4 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.
Where KFX's grants concentrate
KFX Medical, LLC is a focused PatentsView assignee: 2 CPC subclasses with 100% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2015 (4 grants) versus a trough of 1 in 2016. By volume, KFX sits between Kenda Rubber IND. Co., Ltd. and Kinetrol Limited.
Who files at KFX's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Kenda Rubber IND
Kenda Rubber IND. Co., Ltd.
7 patents
- Kenzo
KENZO
7 patents
- KEY DH IP /IP Str…
KEY DH IP INC./IP Strategiques DH, Inc.
7 patents
- Keya Medical Tech…
Keya Medical Technology Co., Ltd.
7 patents
- Kibow Biotech
Kibow Biotech Inc.
7 patents
- Kietta
Kietta
7 patents
- Kimberbell Kids L…
Kimberbell Kids, L.L.C.
7 patents
- Kinetrol
Kinetrol Limited
7 patents
- KFX Medical ◀
KFX Medical, LLC
7 patents
What this shows KFX holds 7 patents at rank #36,082, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near KFX
By rank, the assignees closest to #36,082 in granted patent volume.
- Kenda Rubber IND. Co., Ltd. #36,078 · 7 patents
- KENZO #36,079 · 7 patents
- KEY DH IP INC./IP Strategiques DH, Inc. #36,080 · 7 patents
- Keya Medical Technology Co., Ltd. #36,081 · 7 patents
- Kibow Biotech Inc. #36,083 · 7 patents
- Kietta #36,084 · 7 patents
- Kimberbell Kids, L.L.C. #36,085 · 7 patents
- Kinetrol Limited #36,086 · 7 patents
Leaders in A61B (Diagnosis)
Other assignees with the most granted patents in KFX's primary technology class.
- Covidien LP 5,709 in class
- Koniniklijke Philips N.V. 3,414 in class
- Olympus Corporation 2,758 in class
- Boston Scientific Scimed, Inc. 2,362 in class
- Cilag GmbH International 2,063 in class
- Intuitive Surgical Operations, Inc. 1,921 in class
- DePuy Synthes Products, Inc. 1,796 in class
- Ethicon, Inc. 1,762 in class
KFX's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
22 10th percentile higher than 10% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 4 | 57.1% |
| 2016 | 1 | 14.3% |
| 2017 | 1 | 14.3% |
| 2020 | 1 | 14.3% |
Which technologies does KFX Medical, LLC patent most?
Top 2 of 2 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
KFX Medical, LLC's patent record in context - here's where to go next.
- KFX Medical, LLC's lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 100% of its portfolio - see every assignee active in that class. Explore A61B
- Ranked #36,117 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare KFX Medical, LLC against Kenda Rubber IND. Co., Ltd., an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 22.0/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.